RobertAlanHromasMDFACP
Hematology • San Antonio, TXHematologic Oncology
Dean, Long School of Medicine, UT Health San Antonio
Dr. Hromas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7979 Wurzbach Road
San Antonio, TX 78229Phone+1 210-450-1143Fax+1 210-450-0407
Summary
- Dr. Robert Hromas is a hematologist in San Antonio, TX and is affiliated with multiple hospitals in the area, including University Health / UT Health Science Center at San Antonio and University Health / UT Health Science Center at San Antonio. He received his medical degree from McGovern Medical School at UTHealth and has been in practice 35 years. He specializes in hematologic oncology. He has more than 200 publications and over 10,000 citations.
Education & Training
University of WashingtonFellowship, Hematology, 1988 - 1990
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1984 - 1988
University of Iowa (Des Moines)Internship, Internal Medicine, 1984 - 1985
McGovern Medical School at UTHealthClass of 1984
Certifications & Licensure
TX State Medical License 2018 - 2026
FL State Medical License 2011 - 2019
NM State Medical License 2003 - 2011
WA State Medical License 1988 - 1991
IA State Medical License 1984 - 1990
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Targeting cIAP2 in a novel senolytic strategy prevents glioblastoma recurrence after radiotherapy.Nozomi Tomimatsu, Luis Fernando Macedo Di Cristofaro, Suman Kanji, Lorena Samentar, Benjamin Russell Jordan
EMBO Molecular Medicine. 2025-02-19 - PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1.Juyeong Hong, Pinpin Sui, Ying Li, Kerryn Y Xu, Ji-Hoon Lee
Cell Stem Cell. 2025-02-12 - A BCL-xL/BCL-2 PROTAC effectively clears senescent cells in the liver and reduces MASH-driven hepatocellular carcinoma in mice.Yang Yang, Natacha Jn-Simon, Yonghan He, Chunbao Sun, Peiyi Zhang
Nature Aging. 2025-01-31
Press Mentions
Building a Pipeline of Health Care Excellence to Serve South TexasFebruary 3rd, 2025- UT Health San Antonio Receives $400,000 Donation from IBC Foundation for Diabetes-Related Kidney Disease ResearchDecember 30th, 2024
- Building Hope: UT Health San AntonioDecember 9th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
